AUTOLOGOUS STEM CELL TRANSPLANTATION AS FRONT LINE THERAPY DOES NOT IMPROVE THE OUTCOME OF HIGH RISK AGGRESSIVE NON-HODGKIN'S LYMPHOMA: A SINGLE CENTER STUDY

被引：0
|
作者：
Won, J. -H [1 ]
Yun, J. [1 ]
Kim, H. J. [1 ]
Kim, K. H. [1 ]
Kim, S. -H [1 ]
Lee, S. -C [1 ]
Kim, H. J. [1 ]
Bae, S. B. [1 ]
Kim, C. K. [1 ]
Lee, N. S. [1 ]
Lee, K. -T [1 ]
Park, S. K. [1 ]
Hong, D. S. [1 ]
Park, H. S. [1 ]
机构：
[1] Soonchunhyang Univ Hosp, Seoul, South Korea
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2011年 / 17卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2010.12.301
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
271
引用
收藏
页码：S252 / S252
页数：1
相关论文
共 50 条
  • [21] The Outcome of Autologous Hematopoietic Cell Transplantation in Elderly Patients with Aggressive Non-Hodgkin Lymphoma
    Osmanilhan
    Seval, Guldane Cengiz
    Bozdag, Sinem Civriz
    Toprak, Selami kocak
    Yuksel, Meltem Kurt
    Topcuoglu, Pervin
    Arslan, Onder
    Ozcan, Muhit
    Demirer, Taner
    Gurman, Gunhan
    Beksac, Meral
    BLOOD, 2021, 138
  • [22] Autologous stem cell transplantation in follicular non-Hodgkin's lymphoma
    Pettengell, R
    BONE MARROW TRANSPLANTATION, 2002, 29 (Suppl 1) : S1 - S4
  • [23] Autologous stem cell transplantation in patients with non-Hodgkin's lymphoma
    Prinz, E
    Mitterbauer, M
    Keil, F
    Kalhs, P
    Mitterbauer, G
    Höcker, P
    Jäger, U
    Chott, A
    Mannhalter, C
    Greinix, H
    BONE MARROW TRANSPLANTATION, 2001, 27 : S272 - S272
  • [24] Autologous stem cell transplantation for clinically aggressive non-Hodgkin's lymphoma:: the role of preparative regimens
    Salar, A
    Sierra, J
    Gandarillas, M
    Caballero, MD
    Manín, J
    Lahuerta, JJ
    García-Conde, J
    Arranz, R
    León, A
    Zuazu, J
    García-Laraña, J
    López-Guillermo, A
    Sanz, MA
    Grañena, A
    García, JC
    Conde, E
    BONE MARROW TRANSPLANTATION, 2001, 27 (04) : 405 - 412
  • [25] Laboratory and imaging markers for prediction of outcome in aggressive non-hodgkin lymphoma undergoing autologous stem cell transplantation
    Pilar Gonzalez-Rodriguez, Ana
    Zanabili, Joud
    Palomo, Pilar
    Julia Gonzalez-Huerta, Ana
    Menendez Parron, Aida
    Zambrano, Javier
    Gonzalez-Muniz, Soledad
    BONE MARROW TRANSPLANTATION, 2019, 54 : 462 - 463
  • [26] Autologous stem cell transplantation for clinically aggressive non-Hodgkin's lymphoma: the role of preparative regimens
    A Salar
    J Sierra
    M Gandarillas
    MD Caballero
    J Marín
    JJ Lahuerta
    J García-Conde
    R Arranz
    A León
    J Zuazu
    J García-Laraña
    A López-Guillermo
    MA Sanz
    A Grañena
    JC García
    E Conde
    Bone Marrow Transplantation, 2001, 27 : 405 - 412
  • [27] Comorbidity at Relapse Is An Independent Predictor for Eligibility and Outcome of Autologous Stem Cell Transplantation in Aggressive Non-Hodgkin Lymphoma
    Plattel, Wouter J.
    Kluin-Nelemans, Hanneke C.
    de Bock, Geertruida H.
    van Imhoff, Gustaaf
    BLOOD, 2009, 114 (22) : 914 - 914
  • [28] Outcome after high-dose chemotherapy and autologous stem cell transplantation in patients with aggressive B-cell non-Hodgkin's lymphoma
    Kriegsmann, Katharina
    Rieger, Michael
    Schwarzbich, Mark-Alexander
    Sitter, Soeren
    Kriegsmann, Mark
    Bruckner, Thomas
    Hensel, Manfred
    Ho, Anthony Dick
    Witzens-Harig, Mathias
    Wuchter, Patrick
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 101 (01) : 12 - 20
  • [29] High-dose therapy and autologous stem cell transplantation for high-risk Hodgkin's lymphoma: a single center experience
    Sperotto, A
    Zaja, F
    Damiani, D
    Patriarca, F
    Geromin, A
    Fanin, R
    HAEMATOLOGICA, 2001, 86 (12) : 1317 - 1318
  • [30] High-dose therapy with autologous transplantation for aggressive non-Hodgkin's lymphoma: The Bologna experience
    Zinzani, PL
    Tani, M
    Gabriele, A
    Gherlinzoni, F
    De Vivo, A
    Ricci, P
    Bandini, G
    Lemoli, RM
    Motta, MR
    Rizzi, S
    Guidice, V
    Zompatori, M
    Stefoni, V
    Alinari, L
    Musuraca, G
    Marchi, E
    Bassi, S
    Conte, R
    Pileri, S
    Tura, S
    Baccarani, M
    LEUKEMIA & LYMPHOMA, 2004, 45 (02) : 321 - 326
12345